
CureVac NV
NASDAQ:CVAC

Intrinsic Value
The intrinsic value of one
CVAC
stock under the Base Case scenario is
9.94
USD.
Compared to the current market price of 3.21 USD,
CureVac NV
is
Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CureVac NV
Fundamental Analysis


Revenue & Expenses Breakdown
CureVac NV
Balance Sheet Decomposition
CureVac NV
Current Assets | 526.4m |
Cash & Short-Term Investments | 485.4m |
Receivables | 22.6m |
Other Current Assets | 18.4m |
Non-Current Assets | 276.4m |
PP&E | 244.7m |
Intangibles | 25.2m |
Other Non-Current Assets | 6.6m |
Free Cash Flow Analysis
CureVac NV
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
CureVac NV
Revenue
|
535.2m
EUR
|
Cost of Revenue
|
-105.8m
EUR
|
Gross Profit
|
429.4m
EUR
|
Operating Expenses
|
-251.7m
EUR
|
Operating Income
|
177.7m
EUR
|
Other Expenses
|
-15.5m
EUR
|
Net Income
|
162.2m
EUR
|
CVAC Profitability Score
Profitability Due Diligence
CureVac NV's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
CureVac NV's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
CVAC Solvency Score
Solvency Due Diligence
CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CVAC Price Targets Summary
CureVac NV
According to Wall Street analysts, the average 1-year price target for
CVAC
is 7.87 USD
with a low forecast of 2.53 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for CVAC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CVAC
stock under the Base Case scenario is
9.94
USD.
Compared to the current market price of 3.21 USD,
CureVac NV
is
Undervalued by 68%.